| |
 |
Details: |
 |
|
|
An angiotensin II receptor antagonist, which acts specifically on the receptor that triggers increased blood pressure. Intended for physicians in the Philippines.
|
| URL: |
http://teveten.com.ph
|
| Title: |
teveten.com.ph |
| Image: |
 |
| Description: |
Health, Pharmacy, Drugs and Medications, E - Eprosartan Mesylate ( Teveten ) By Solvay Pharmaceuticals, Inc.. An angiotensin II receptor antagonist, which acts specifically on the receptor that triggers increased blood pressure. |
| Similar: |
|
|
|
Related Sites |
|
Raptiva - Genentech (Popularity:  ): Official pharmaceutical site with information for patients and health professionals.
Lovenox (Popularity: ): Enoxaparin sodium. Features information for patients and physicians including tips and instructions, interactions, prescribing information, description of potential uses, and ...
Drugs.com: Inspra (Popularity: ): Information for patients in FAQ format.
Nexium (Esomeprazole) - AstraZeneca (Popularity: ): Official Pharmaceutical website intended for consumers with link to site for health professionals.
Estrasorb (Popularity: ): Information about the soy-based emulsion skin lotion from the manufacturer, Novavax.
Vaniqa (Popularity: ): Features, eflornithine hydrochloride, a prescription cream that slows the growth of woman's unwanted facial hair.
Zetia (Ezetimibe) (Popularity: ): Manufacturer's information for consumers and healthcare professionals including prescribing information in PDF format.
Comtan (entacapone) - Novartis (Popularity: ): Official pharmaceutical site for this drug used in the treatment of Parkinson's Disease as an adjunct to levodopa/carbidopa therapy.
Procrit ( Erythropoietin ) (Popularity: ): Manufacturer's information on this medication intended to increase red blood cell production in the treatment of fatigue and anemia.
Enbrel - Immunex (Popularity: ): Etanercept. FDA-approved to treat rheumatoid arthritis, psoriasis, ankylosing spondylitis, psoriatic arthritis, and juvenile rheumatoid arthritis. Official pharmaceutical website.
|
|
Popular Sites |
|
Enbrel - Immunex (Popularity: ): Etanercept. FDA-approved to treat rheumatoid arthritis, psoriasis, ankylosing spondylitis, psoriatic arthritis, and juvenile rheumatoid arthritis. Official pharmaceutical website.
Procrit ( Erythropoietin ) (Popularity: ): Manufacturer's information on this medication intended to increase red blood cell production in the treatment of fatigue and anemia.
Comtan (entacapone) - Novartis (Popularity: ): Official pharmaceutical site for this drug used in the treatment of Parkinson's Disease as an adjunct to levodopa/carbidopa therapy.
Zetia (Ezetimibe) (Popularity: ): Manufacturer's information for consumers and healthcare professionals including prescribing information in PDF format.
Vaniqa (Popularity: ): Features, eflornithine hydrochloride, a prescription cream that slows the growth of woman's unwanted facial hair.
|
|
Related Press |
|
Great Lakes Pharmaceuticals, Inc., Announces $2.4 Million Equity Financing (Popularity: ): Great Lakes Pharmaceuticals, Inc. announced today the completion of Series A $2.4 million equity financing led by Ohio investment funds ...
Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease (Popularity: ): Iodine has been used as an antimicrobial for the last century. Much has been written about molecular iodine yet many ...
Watson' Launches Generic Kadian(R) (Popularity: ): PARSIPPANY, N.J., Nov. 10, 2011 -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that it has received approval from the ...
Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis (Popularity: ): Cerimon Pharmaceuticals, Inc., announced today it has initiated a Phase II proof-of-concept study of Simulect(R) (basiliximab) for the treatment of ...
DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease (Popularity: ): Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs, announced today that after completing its review of safety ...
|
|
Related Articles |
|
|
|
